{"symbol":"DHR","fiscalQuarter":"Q1-2017","reportDate":"2017-04-20","reportTime":"BMO","status":"reported","company":{"name":"Danaher Corporation","sector":"Health Care","industry":"Life Sciences Tools & Services"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/DHR/earnings/Q1-2017","postBrief":{"headline":"Danaher Corp Beats on EPS, Stock Down 4.11%","keyNumbers":[{"metric":"EPS","actual":"$0.85","expected":"N/A","surprise":"+1.07%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized a focus on operational efficiency moving forward."],"summary":"Overall, management expressed caution regarding market conditions. They are prioritizing efficiency but did not provide specific guidance."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Danaher Corp's earnings report shows a slight beat on EPS, which indicates some positive performance. However, the stock dropped by 4.11%, likely due to concerns over market conditions and the lack of specific guidance. Investors may be wary of the company's ability to navigate challenges ahead.","metaDescription":"Danaher Corp (DHR) Q1 2017 earnings: EPS beat by 1.07%. Stock down 4.11%. Full breakdown."}}